Central Venous Catheter Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
CENTRAL VENOUS CATHETER MARKET ANALYSIS

• Central Venous Catheter Market, By Product Type
  (Tunneled Catheters, Non-Tunneled Catheters), By
  Property (Anti-Microbial Catheter, Non-
  Anti-Microbial Catheter), By Design (Single
  Lumen, Double Lumen, Multi Lumen), By Composition
  (Polyurethane, Polyurethane/Polycarbonate,
  Silicone), By End User (Hospitals, Ambulatory
  Surgical Centers, Speciality Clinics Others),
  and By Region (North America, Latin America,
  Europe, Asia Pacific, Middle East Africa) -
  Size, Share, Outlook, and Opportunity Analysis,
  2019 - 2027
• The global central venous catheter market is
  estimated to account for US 778.0 Mn in terms of
  value in 2019 and is expected to reach US
  1,164.5 Mn by the end of 2027.

3
Global Central Venous Catheter Market Drivers

• Increasing prevalence of diseases that require
  long-term therapies such as cancer (chemotherapy)
  and end stage renal disease (dialysis) is
  expected to fuel growth of the U.S. Central
  Venous Catheter Market. For instance, according
  to the World Health Organization, around 18.1
  million new cases and 9.6 million deaths were
  registered due to cancer worldwide in 2018.
• Moreover, high incidence of renal diseases is
  also expected to aid in the market growth. For
  instance, according to European Renal Association
  European Dialysis and Transplant Associations
  data in 2018, over 850 million people worldwide
  have some form of kidney disease.

4
Statistics

• Asia Pacific region held dominant position in the
  global central venous catheter market in 2018,
  accounting for 30.1 share in terms of value,
  followed by North America.

5
Global Central Venous Catheter Market Restraints

• High cost of antimicrobial-coated catheters is
  expected to hinder growth of the global central
  venous catheter market. The average cost of an
  antimicrobial coated catheter is four times more
  than the cost of normal catheters without
  coating. This may lead to high preference for
  non-antimicrobial coated catheters to minimize
  the cost of surgery.
• Moreover, there are significant risks and
  complications associated with central venous
  catheterization procedures such as bleeding,
  damage to blood vessel, arterial puncture,
  hematoma, and pneumothorax. Use of central venous
  catheters can also lead to infection at the
  insertion site of the catheter, contamination of
  the catheter, and haematogenous seeding of the
  catheter. This in turn is expected to hinder
  growth of the market.

6
Global Central Venous Catheter Market
Opportunities

• Introduction of catheters with antimicrobial
  protection is expected to offer lucrative growth
  opportunities for players in the global central
  venous catheters market. For instance, in July
  2019, researchers from Nottingham University
  reported development of a Bactigon, a new family
  of biomaterials that have a major impact against
  antimicrobial resistance (AMR).
• Major regulatory bodies are focused on offering
  guidance for product approval, which is expected
  to offer lucrative growth opportunities for
  players in the market. For instance, in January
  2020, the U.S. FDA released draft guidance
  detailing the information device-makers should
  include in 510(k) submissions of catheter-based
  devices intended to treat peripheral vasculature
  lesions.
• Product type segment in the global central venous
  catheter market is estimated to be valued at US
  778.0 Mn in 2019 and is expected to reach US
  1,164.5 Mn by 2026 at a CAGR of 5.1 during the
  forecast period.

7
Market Trends/Key Takeaways

• The use of evidence-based care bundles reinforced
  by real-time feedback has led to significant
  decrease in rate of catheter-related bloodstream
  infection in the intensive care unit. This in
  turn is expected to aid in growth of the market.
• The use of central venous catheter in
  administering chemotherapy drugs has increased
  significantly. This is owing to various benefits
  of central venous catheters such it helps to
  avoid serious damage to skin and muscle tissue
  from drugs that are capable of such adverse
  effects if they leak outside a vein.

8
Regulations

• U.S.
• The U.S. FDA authorized use of mono, duo, trio,
  Quattro lumen central venous catheters, as they
  fall under class II
• Therefore, companies do not require a premarket
  approval before commercializing the device for
  central access procedures. However, a 510K
  approval is still necessary
• According to the Federal Food, Drug and Cosmetic
  Act (Act), central venous catheters comes under
  class II and do not require approval i.e.
  premarket approval application (PMA). However the
  device is marketed under general controls
  provisions of the Act. which includes
  requirements for annual registration, listing of
  devices, good manufacturing practice, labeling
  and prohibitions against misbranding and
  adulteration.

9
Value Chain Analysis
10
(No Transcript)
11
Global Central Venous Catheter Market
Competitive Landscape

• Major players operating in the global central
  venous catheter market include, AngioDynamics,
  C.R. Bard, Teleflex Incorporated, B. Braun
  Melsungen AG, Kimal, Comed B.V., Medtronic Plc.,
  Smiths Medical, Inc., and Vygon Group.

12
Global Central Venous Catheter Market Key
Developments

• Major players in the market are focused on
  adopting MA strategies to expand their product
  portfolio. For instance, in October 2019, Vygon
  Group acquired Pilot, an Italy-based ECG central
  venous catheter tip location and navigation
  devices manufacturer.
• Major players in the market are also focused on
  adopting various marketing strategies to enhance
  their market share. For instance, in November
  2019, Teleflex Incorporated showcased its
  Interventional product portfolio including the
  MANTA Vascular Closure Device and Langston Dual
  Lumen Catheters at the PCR London Valves held in
  London.

13

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/central-venous-catheter-market-240
  0

14
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

15
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

16

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/